Key Decisions and Approvals

The Board of Directors, in a meeting held on October 28, 2026 (commencing at 03:09 PM IST and concluding at 04:45 PM IST), considered and approved the following items:

1. Unaudited Financial Results: Approved the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The results were reviewed by the Audit Committee and the Statutory Auditors have issued Limited Review Reports.

2. Capital Expenditure Project: Approved a proposal to set up a Borosilicate 3.3 glass tubing furnace at the company's plant in Bharuch.

Detailed Financial Results (Standalone)

Income Statement Highlights (₹ Lakhs)

Quarter Ended September 30, 2026 (Q2 FY27):

  • Revenue from Operations: 10,419.39
  • Other Income: 262.04
  • Total Income: 10,681.43
  • Profit Before Tax (PBT): 893.10
  • Total Tax Expense: 268.12
  • Profit for the Period (PAT): 624.98
  • Total Comprehensive Income: 618.56
  • Basic & Diluted EPS (not annualized): ₹0.10

Half Year Ended September 30, 2026 (H1 FY27):

  • Revenue from Operations: 20,409.07
  • Other Income: 541.66
  • Total Income: 20,950.73
  • Profit Before Tax (PBT): 1,824.21
  • Total Tax Expense: 514.88
  • Profit for the Period (PAT): 1,309.33
  • Total Comprehensive Income: 1,296.62
  • Basic & Diluted EPS (not annualized): ₹1.47

Comparatives:

  • H1 FY26 PAT: ₹797.82 Lakhs | H1 FY27 PAT: ₹1,309.33 Lakhs
  • FY26 (Full Year) PAT: ₹3,972.46 Lakhs

Segment-Wise Performance (H1 FY27, ₹ Lakhs)

Following a segmental realignment, performance for H1 FY27 is:

  • Scientific - Laboratory Glass & Equipment and Process System: Revenue: 12,981.78 | PBT: 2,728.72
  • Primary Pharma Packaging: Revenue: 4,402.21 | PBT: (314.27) Loss
  • Consumer Glassware: Revenue: 3,025.08 | PBT: 158.79

Balance Sheet Highlights (Standalone as of September 30, 2026, ₹ Lakhs)

  • Total Assets: 55,831.02
  • Total Equity: 47,549.47
  • Paid-up Equity Share Capital: 889.52 (Face value Re. 1/- each)

Cash Flow Highlights (Standalone H1 FY27, ₹ Lakhs)

  • Net Cash from Operating Activities: 1,772.43
  • Net Cash used in Investing Activities: (1,934.35)
  • Net Cash used in Financing Activities: (4.65)
  • Net Decrease in Cash and Equivalents: (166.57)

Detailed Financial Results (Consolidated)

Income Statement Highlights (₹ Lakhs)

Quarter Ended September 30, 2026 (Q2 FY27):

  • Revenue from Operations: 11,496.37
  • Profit for the Period (PAT) attributable to owners: 531.25
  • Basic & Diluted EPS (not annualized): ₹0.60

Half Year Ended September 30, 2026 (H1 FY27):

  • Revenue from Operations: 22,171.60
  • Profit for the Period (PAT) attributable to owners: 968.33
  • Basic & Diluted EPS (not annualized): ₹1.09

Subsidiary Impact:

The results include the financials of subsidiary Goel Scientific Glass Works Limited, which for H1 FY27 contributed Revenue of ₹1,890.72 Lakhs and a Net Loss of ₹(321.05) Lakhs.

Capital Expenditure Project Details

The approved project involves setting up a Borosilicate 3.3 glass tubing furnace. The details as per Reg. 30 annexure are:

  • Existing Capacity: Nil
  • Proposed Capacity Addition: ~20 Metric Tonnes (MT) per day
  • Expected Commencement: Commercial production by March 31, 2028
  • Investment Required: Capital expenditure of up to ₹70 crores
  • Mode of Financing: Internal accruals and/or borrowings
  • Rationale: The project is intended for backward integration, as the tubing is a key raw material currently imported. It aims to reduce import dependence, improve supply-chain reliability, control quality/availability, and optimize manufacturing costs. Output will be primarily for captive consumption, with surplus sold externally. The company will apply for subsidy benefits under the 'Viksit Gujarat Industrial Policy 2026'.

Other Material Information

1. Exceptional Items: The comparative figures for H1 FY25 and FY26 include exceptional items of ₹661.31 Lakhs (Voluntary Retirement Scheme cost at Nashik plant) and ₹191.51 Lakhs (one-time impact of new Labour Codes implementation). There are no exceptional items in the current period (H1 FY27).

2. ESOP Allotment: The company allotted 4,475 equity shares (face value Re. 1/- each) during H1 FY27 pursuant to the exercise of options under the BSL ESOS, increasing paid-up capital by ₹0.05 Lakhs and securities premium by ₹7.48 Lakhs.

3. Segment Realignment: The company has changed its internal reporting structure, splitting the previous 'Glassware' segment into 'Primary Pharma Packaging' and 'Consumer Glassware'. Comparative segmental data has been restated accordingly.